Junghui Koo

426 total citations
10 papers, 280 citations indexed

About

Junghui Koo is a scholar working on Molecular Biology, Cell Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Junghui Koo has authored 10 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Cell Biology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Junghui Koo's work include PI3K/AKT/mTOR signaling in cancer (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related gene regulation (2 papers). Junghui Koo is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (6 papers), Ubiquitin and proteasome pathways (5 papers) and Cancer-related gene regulation (2 papers). Junghui Koo collaborates with scholars based in United States, China and India. Junghui Koo's co-authors include Shi‐Yong Sun, Fadlo R. Khuri, Ping Yue, Xingming Deng, Zixu Mao, Xiaoyun Wu, Suresh S. Ramalingam, Hui Ren, Taofeek K. Owonikoko and Baoxiang Guan and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Junghui Koo

10 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junghui Koo United States	6	240	83	40	27	25	10	280
Harriet Southgate United Kingdom	4	230 1.0×	131 1.6×	41 1.0×	34 1.3×	18 0.7×	4	288
Patrick Jaynes Singapore	7	232 1.0×	97 1.2×	44 1.1×	13 0.5×	17 0.7×	12	270
Leslie H. Brail United States	8	294 1.2×	85 1.0×	45 1.1×	45 1.7×	43 1.7×	16	385
Kıvanç Görgülü Germany	6	133 0.6×	55 0.7×	53 1.3×	40 1.5×	25 1.0×	14	228
Sandra Baumgart Germany	6	238 1.0×	156 1.9×	54 1.4×	16 0.6×	37 1.5×	6	313
Jingying Cao China	7	237 1.0×	68 0.8×	68 1.7×	29 1.1×	16 0.6×	11	289
Liting Xue United States	8	224 0.9×	46 0.6×	39 1.0×	13 0.5×	32 1.3×	20	368
Franziska Trippel Germany	5	304 1.3×	85 1.0×	70 1.8×	24 0.9×	10 0.4×	7	366
Zheng Zhong Singapore	6	287 1.2×	103 1.2×	81 2.0×	36 1.3×	20 0.8×	8	355
H. Nikki March United Kingdom	5	228 0.9×	83 1.0×	80 2.0×	16 0.6×	30 1.2×	5	296

Countries citing papers authored by Junghui Koo

Since Specialization

Citations

This map shows the geographic impact of Junghui Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junghui Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junghui Koo more than expected).

Fields of papers citing papers by Junghui Koo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junghui Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junghui Koo. The network helps show where Junghui Koo may publish in the future.

Co-authorship network of co-authors of Junghui Koo

This figure shows the co-authorship network connecting the top 25 collaborators of Junghui Koo. A scholar is included among the top collaborators of Junghui Koo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junghui Koo. Junghui Koo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Koo, Junghui, Chang-Soo Seong, Rebecca E. Parker, et al.. (2024). Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1 -Mutant Lung Cancer. Cancer Research. 84(22). 3761–3771. 3 indexed citations

Sharma, Richa, Janna K. Mouw, Junghui Koo, et al.. (2024). Intra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981. iScience. 27(11). 111133–111133. 2 indexed citations

Koo, Junghui, Xiaoyun Wu, Zixu Mao, Fadlo R. Khuri, & Shi‐Yong Sun. (2015). Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation. Journal of Biological Chemistry. 290(22). 14120–14129. 59 indexed citations

Koo, Junghui, Ping Yue, Xingming Deng, Fadlo R. Khuri, & Shi‐Yong Sun. (2015). mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation. Molecular and Cellular Biology. 35(13). 2344–2355. 46 indexed citations

Koo, Junghui, Xuerong Wang, Taofeek K. Owonikoko, et al.. (2015). GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth. Oncotarget. 6(11). 8974–8987. 16 indexed citations

Koo, Junghui, et al.. (2015). Rictor undergoes GSK3-dependent, FBXW7-mediated ubiquitination and proteasomal degradation. 2 indexed citations

Koo, Junghui, Ping Yue, Anthony A. Gal, Fadlo R. Khuri, & Shi‐Yong Sun. (2014). Maintaining Glycogen Synthase Kinase-3 Activity Is Critical for mTOR Kinase Inhibitors to Inhibit Cancer Cell Growth. Cancer Research. 74(9). 2555–2568. 37 indexed citations

Koo, Junghui, Ping Yue, Fadlo R. Khuri, & Shi‐Yong Sun. (2014). Abstract 349: mTOR complex 2 (mTORC2) positively regulates Mcl-1 stability by suppressing GSK3-dependent and FBXW7-mediated proteasomal degradation of Mcl-1. Cancer Research. 74(19_Supplement). 349–349. 1 indexed citations

Ren, Hui, Junghui Koo, Baoxiang Guan, et al.. (2013). The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis. Molecular Cancer. 12(1). 146–146. 65 indexed citations

10.

Li, Yikun, Songqing Fan, Junghui Koo, et al.. (2012). Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer. Cancer Biology & Therapy. 13(5). 272–280. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact